Chrs stock price - CHRS Stock 12 Months Forecast. $9.60. (303.36% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Coherus Biosciences in the last 3 months. The average price target is $9.60 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 303.36% change from the last price of $2.38.

 
Chrs stock price

Coherus Bio stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... CHRS Stock Quotes API . CHRS Related ETF s. …Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody. Shares of Coherus BioSciences, Inc. CHRS were up 23.4% on Dec 27 after the company announced that the FDA has approved Udenyca Onbody ...REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that …Coherus BioSciences Inc. CHRS.C. Latest Trade. 2.02 USD. -0.05. -2.42%. As of Feb 5, 2024. Values delayed up to 15 minutes. Today's Range.The current average CHRS price target, as estimated by these analysts, is $9.00. The predictions for the future CHRS stock price range from a low of $7.00 to a high of $11.00 , highlighting the variability of market expectations for CHRS .Is Coherus BioSciences Stock Undervalued? The current Coherus BioSciences [CHRS] share price is $2.13. The Score for CHRS is 14, which is 72% below its historic ...2 days ago · CHRS is the ticker symbol for Coherus BioSciences Inc., a biotech company that develops and sells cancer treatments. The stock price, news, analysis, and performance of CHRS are shown on the web page. As of Jan 24, 2024, the stock price was $2.3000, down 4.17% from the previous close. Find the historical stock prices of Coherus BioSciences (CHRS)Measures a public company's total equity value as implied by the stock's last observed trading price. In the case of cryptocurrencies, it measure the .Complete Coherus BioSciences Inc. stock information by Barron's. View real-time CHRS stock price and news, along with industry-best analysis.See Coherus BioSciences, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading ...Coherus Biosciences Inc (CHRS) current stock price is $2.31 with a 24-hour trading volume of 6.87M. The stock increased by +0.43% in the last 24 hours and declined by -30.63% in the past month. CHRS chart suggests a potential bullish trend as CHRS stock price is above the pivot point level of $2.30, if it continues to reach close to the resistance level of …Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress. Find the latest Coherus BioSciences, Inc. (CHRS) stock quote, history, news and other vital information to help you with your stock trading and investing.Coherus BioSciences Inc stock price live 2.47, this page displays NASDAQ CHRS stock exchange data. View the CHRS premarket stock price ahead of the market session or assess the after hours quote.Find the latest Carpenter Technology Corporation (CRS) stock quote, history, news and other vital information to help you with your stock trading and investing.Coherus Biosciences Inc (CHRS) stock is trading at $2.44 as of 10:16 AM on Wednesday, Jan 24, a gain of $0.04, or 1.85% from the previous closing price of $2.40. The stock has traded between $2.34 and $2.50 so far today. Volume today is below average.Nov 13, 2023 · CHRS stock closed at $1.59 and is up $0.05 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CHRS has a roughly average overall score of 36 meaning the stock holds a better value than 36% of stocks at its current price. Darren415. Coherus BioSciences (NASDAQ:CHRS) was trading around +8% in premarket hours on Friday after Baird began coverage of the stock with an Outperform rating.Baird cited multiple tailwinds ...Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress. Find the latest Coherus …The Coherus BioSciences stock forecast for tomorrow is $ 2.63, which would represent a 0.00% gain compared to the current price. In the next week, the price of CHRS is expected to decrease by -0.99% and hit $ 2.60.. As far as the long-term Coherus BioSciences stock forecast is concerned, here’s what our predictions are currently suggesting.Coherus Biosciences Inc (CHRS) Stock Price & News - Google Finance Home CHRS • NASDAQ Coherus Biosciences Inc Follow Share $2.76 After Hours: $2.70 (2.17%) -0.060 Closed: Feb 16, 7:57:19 PM... Coherus’ immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust immunologic response and enhance outcomes for patients with cancer. The foundational therapy in our immuno-oncology pipeline is LOQTORZI, a …Get the latest stock price, quote, news and history of Coherus BioSciences, Inc. Common Stock (CHRS), a biotechnology company that develops and commercializes therapies …The above table shows the analyst CHRS forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.48Coherus BioSciences, Inc. Common Stock (CHRS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. A high-level overview of Coherus BioSciences, Inc. (CHRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Jan 4, 2024 · CHRS support price is $2.79 and resistance is $3.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CHRS stock will trade within this expected range on the day. View a ... View the real-time CHRS price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd.co/fees to learn more.Coherus BioSciences Stock Earnings. The value each CHRS share was expected to gain vs. the value that each CHRS share actually gained. Coherus BioSciences ( CHRS) reported Q3 2023 earnings per share (EPS) of -$0.41, missing estimates of -$0.39 by 3.92%. In the same quarter last year, Coherus BioSciences 's earnings per share (EPS) was -$1.11. Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Coherus BioSciences (CHRS) ... Coherus (CHRS) Stock Rises on BLA Re-Filing for Udenyca Onbody ...Coherus Biosciences Inc has fallen 11.11% over the past month, closing at $3.47 on October 5. During this period of time, the stock fell as low as $2.64 and as high as $3.98. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $13.13.4 days ago · Complete Coherus BioSciences Inc. stock information by Barron's. View real-time CHRS stock price and news, along with industry-best analysis. The average one-year price target for Coherus BioSciences, Inc. is $12.58. The forecasts range from a low of $7.07 to a high of $24.15. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their ...Coherus BioSciences Inc (CHRS) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. ... The current price of CHRS is $2.31. The 52 week high of CHRS is $9.13 and 52 week low is $1.43. When is next earnings date of Coherus BioSciences Inc(CHRS)?19 Aug 2021 ... Coherus Bioscienes ($CHRS) is finally killing it, here's why you should care. ... stock price that's finally taki by off. Nothing to do with ...Coherus Biosciences Inc (CHRS) current stock price is $2.31 with a 24-hour trading volume of 6.87M. The stock increased by +0.43% in the last 24 hours and declined by -30.63% in the past month. CHRS chart suggests a potential bullish trend as CHRS stock price is above the pivot point level of $2.30, if it continues to reach close to the resistance level of …Coherus BioSciences Inc stock price (CHRS) NASDAQ: CHRS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... CHRS Stock Performance. USD USD; Previous close: 2.09: 2.09: Day range: 1.93 - 2.09851.93 - 2.0985Year range: 1 - 81 - 8Market cap: 229410000: 229410000: Primary ...CHRS, Coherus BioSciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines 13 Sept 2023 ... As of September 13, 2023, 4:00 PM CST, Coherus Biosciences Inc's stock price was $4.68. Coherus Biosciences Inc is down 7.14% from its previous ...19 Aug 2021 ... Coherus Bioscienes ($CHRS) is finally killing it, here's why you should care. ... stock price that's finally taki by off. Nothing to do with ...Coherus BioSciences Inc. CHRS.C. Latest Trade. 2.02 USD. -0.05. -2.42%. As of Feb 5, 2024. Values delayed up to 15 minutes. Today's Range.Find the latest Salesforce, Inc. (CRM) stock quote, history, news and other vital information to help you with your stock trading and investing.3 days ago · What is the target price for Coherus BioSciences (CHRS) stock? A. The latest price target for Coherus BioSciences ( NASDAQ: CHRS) was reported by Baird on Tuesday, January 23, 2024. The analyst ... Overview News Coherus BioSciences Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.61 Market Cap $307.37 M Public Float …The Coherus BioSciences stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of CHRS stock is predicted to rise by 1.23% tomorrow and lose -1.41% in the next 7 days. Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress. Find the latest Coherus BioSciences, Inc. (CHRS) stock quote, history, news and other vital information to help you with your stock trading and investing.Wondering where to invest your money? Compare real estate vs. stocks and find the most profitable investment for your financial situation. Compare real estate vs. stocks and find t...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...CHRS stock quote, chart and news. Get CHRS's stock price today. In conclusion, on January 10, 2024, CHRS experienced a decline in its stock price, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock closed at $2.98, with a 3.25% drop since the market last closed. However, there was a slight increase of $0.01 in pre-market trading, suggesting a …What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...Coherus Biosciences Inc has fallen 11.11% over the past month, closing at $3.47 on October 5. During this period of time, the stock fell as low as $2.64 and as high as $3.98. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $13.13.Coherus BioSciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CHRS stock price. CHRS | Coherus BioSciences Inc. Stock Price & News - WSJ Coherus BioSciences Inc. CHRS (U.S.: Nasdaq) REAL TIME 10:42 AM EST 02/23/24 $2.51 USD 65 Day Avg Vol …If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Coherus Biosciences Inc (CHRS) stock is unchanged 0% while the S&P 500 has fallen -1.16% as of 1:35 PM on Wednesday, Oct 19. CHRS is flat $0.00 from the previous closing price of $8.36 on volume of 392,122 shares. Over the past year the S&P 500 is lower by -18.05% while CHRS has fallen -51.00%. CHRS lost -$2.97 per share in …Stock analysis for Coherus Biosciences Inc (CHRS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The stock price of Coherus Biosciences Inc (NASDAQ: CHRS) has dropped by -8.56 compared to previous close of 2.57. Despite this, the company has seen a fall of -23.70% in its stock price over the last five trading days. ... The predicted price for CHRS in the upcoming period, according to Robert W. Baird is $11 based on the research report ...CHRS stock returns are also predicted based on historical data. According to our research, CHRS stock is a bad long-term investment. CHRS share price has been in a bear cycle for the past year.The average Coherus Biosciences stock price prediction forecasts a potential upside of 257.14% from the current CHRS share price of $2.59. What is CHRS's forecast return on equity (ROE) for 2024-2027?The all-time high Coherus BioSciences stock closing price was 37.46 on July 22, 2015. The Coherus BioSciences 52-week high stock price is 8.65, which is 213.4% above the current share price. The Coherus BioSciences 52-week low stock price is 1.43, which is 48.2% below the current share price. The average Coherus BioSciences stock price for the ... Overview News Coherus BioSciences Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.61 Market Cap $307.37 M Public Float …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...CHRS | Coherus BioSciences Inc. Stock Price & News - WSJ Coherus BioSciences Inc. CHRS (U.S.: Nasdaq) REAL TIME 10:42 AM EST 02/23/24 $2.51 USD 65 Day Avg Vol …Get the detailed quarterly/annual income statement for Coherus BioSciences, Inc. (CHRS). Find out the revenue, expenses and profit or loss over the last fiscal year.Find the historical stock prices of Coherus BioSciences (CHRS)The all-time high Coherus BioSciences stock closing price was 37.46 on July 22, 2015. The Coherus BioSciences 52-week high stock price is 8.65, which is 213.4% above the current share price. The Coherus BioSciences 52-week low stock price is 1.43, which is 48.2% below the current share price. The average Coherus BioSciences stock price for the ... Dec 28, 2023 · Coherus finally received FDA approval for its Udenyca OnBody injector system. Shares of Coherus BioSciences ( CHRS 10.08%) are up 19.7% as of 3:20 p.m. ET Thursday after the U.S. Food and Drug ... 5 days ago · Coherus BioSciences (CHRS) Stock Price, News & Analysis $2.59 -0.17 (-6.16%) (As of 02/20/2024 ET) Compare Today's Range $2.59 $2.78 50-Day Range $1.94 $3.33 52-Week Range $1.43 $8.65 Volume 1.83 million shs Average Volume 5.50 million shs Market Capitalization $288.42 million P/E Ratio N/A Dividend Yield N/A Price Target $11.22 CHRS - Coherus BioSciences, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM) Stock Quote & Chart. NASDAQ: CHRS. $2.47. Feb 22, 2024 4:00 PM EST. Change. -0.01 (-0.40%). Volume. 1,983,422. Today's Open. $2.50. Previous Close. $2.48.CHRS Stock Summary. Coherus Biosciences Inc (NASDAQ:CHRS) stock price today is $2.32, and today's volume is 6,770,930. CHRS is up 0.434% today. The 30 day average volume is 11,684,916. CHRS market cap is …Find the historical stock prices of Coherus BioSciences (CHRS)The 5 analysts with 12-month price forecasts for Coherus BioSciences stock have an average target of 9.60, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 288.66% from the current stock price of 2.47. ... The average analyst rating for CHRS stock from 6 stock analysts is "Strong Buy". This means ...Coherus BioSciences (CHRS) stock surged 8% in reaction to Phase 2 trial data for its liver cancer combination therapy. Read more here.CHRS stock closed at $2.34 and is down -$0.03 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CHRS has a roughly average overall score of 39 meaning the stock holds a better value than 39% of stocks at its current price.CHRS stock experienced a mixed performance on November 18, 2023, according to data from CNN Money. The stock opened at $1.85, higher than the previous close of $1.71. Throughout the day, the stock’s price fluctuated between a low of $1.82 and a high of $2.15. The trading volume for the day was 304,325 shares, significantly lower …CHRS | Complete Coherus BioSciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The current average CHRS price target, as estimated by these analysts, is $9.00. The predictions for the future CHRS stock price range from a low of $7.00 to a high of $11.00 , highlighting the variability of market expectations for CHRS .Real time Coherus BioSciences (CHRS) stock price quote, stock graph, news & analysis.Coherus Bio stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... CHRS Stock Quotes API . CHRS ... CHRS-3.16%. NVS +0.56%. GSK +0.41% ... Coherus will issue shares of its common stock at a price of $5.2831 per share to acquire all outstanding shares of Surface stock for a total value equal to ...Track Charah Solutions Inc (CHRA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe above table shows the analyst CHRS forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.481 Jan 2024 ... CHRS STOCK: EASY MONEY STOCK?? ($CHRS). Top Trader Academy•595 views · 16 ... Price Action Trading like a Pro - I share my best tips after 14 ...CHRS: Coherus BioSciences price and EPS surprise. Get the latest price and EPS surprise information from Zacks Investment Research.Is Coherus BioSciences stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a ...A high-level overview of Coherus BioSciences, Inc. (CHRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. According to 6 analysts, the average rating for CHRS stock is "Strong Buy." The 12-month stock price forecast is $9.6, which is an increase of 270.66% from the …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Coherus BioSciences (CHRS) (Delayed Data from NSDQ) $2.76 USD -0.09 (-3.16%) Updated Feb 16, 2024 04:00 PM ET After-Market: $2.79 +0.03 (1.09%) 7:58 PM …

On Wednesday, Coherus BioSciences Inc (CHRS:NMQ) closed at 2.32, 62.23% above the 52 week low of 1.43 set on Nov 10, 2023. Data delayed at least 15 minutes, as of Feb 07 2024 21:00 GMT. Latest Coherus BioSciences Inc (CHRS:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, …. Cheapest escort

Christ the lord is risen today

Find the latest New York Community Bancorp, Inc. (NYCB) stock quote, history, news and other vital information to help you with your stock trading and investing.Shares of Coherus BioSciences ( CHRS 10.08%) were sinking 8.6% lower as of 11:14 a.m. ET on Tuesday. The decline followed a nice pop for the stock on Monday after Coherus announced it was selling ...Recently. Webull offers CHRS Ent Holdg (CHRS) historical stock prices, in-depth market analysis, NASDAQ: CHRS real-time stock quote data, in-depth charts, free CHRS options chain data, and a fully built financial calendar to help you invest smart. Buy CHRS stock at Webull. Overview News Coherus BioSciences Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.61 Market Cap $307.37 M Public Float …Jan 25, 2024 · Get Coherus BioSciences Inc (CHRS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments The latest price target for . Coherus BioSciences (NASDAQ: CHRS) was reported by Baird on January 23, 2024.The analyst firm set a price target for $9.00 expecting CHRS to rise to within 12 months ...The intrinsic value of one CHRS stock under the Base Case scenario is 12.43 USD. Compared to the current market price of 2.59 USD, Coherus BioSciences Inc is ...Data for Coherus Biosciences | CHRS - Stock including historical, tables and ... USD 0, 0, Jun/2020. Financials. Stock Price · Assets · Cash and Equivalent · C...4.7100. 4.8900. 4.8900. 7,238,200. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for CHRS stock on Yahoo Finance. View daily, weekly or monthly format back to when Coherus BioSciences, Inc. stock was issued.The average trading volume of CHRS on February 22, 2024 was 6.19M shares. CHRS) stock’s latest price update. Coherus Biosciences Inc (NASDAQ: CHRS) has experienced a decline in its stock price by -4.25 compared to its previous closing price of 2.59. However, the company has seen a fall of -3.12% in its stock price over the last five …The 9 analysts offering 1 year price forecasts for CHRS have a max estimate of — and a min estimate of —. Analyst rating Based on 10 analysts giving stock ratings to CHRS in the past 3 months. The stock price has risen from 2 to 2.85 since then --- a parity gap still remains as shown in the attached charts ... CHRS - Volume By Price --- Profit Taking Creating Long Entry Points @ $13 Before Next Leg Up. u/Tone-EEE.Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. Find the latest Salesforce, Inc. (CRM) stock quote, history, news and other vital information to help you with your stock trading and investing..

We would like to show you a description here but the site won’t allow us.

Popular Topics

  • Tapas food

    Def leppard songs | 13 Sept 2023 ... As of September 13, 2023, 4:00 PM CST, Coherus Biosciences Inc's stock price was $4.68. Coherus Biosciences Inc is down 7.14% from its previous ...All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Coherus BioSciences Inc. CHRS.C. Latest Trade. 2.02 USD. -0.05. -2.42%. As of Feb 5, 2024. Values delayed up to 15 minutes. Today's Range....

  • Dust in wind lyrics

    Free download game solitaire spider | CHRS Stock 12 Months Forecast. $9.60. (303.36% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Coherus Biosciences in the last 3 months. The average price target is $9.60 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 303.36% change from the last price of $2.38.Coherus BioSciences careened $2.22 (-27.2%) to $5.93 on light volume today. That could be a correction from yesterday when closing price saw a big increase. The BioPharmCatalyst Index edged up 0.21 (+0.19%) to 106.1 today. That is the highest it has been since February 7th.Options Chain Tools: Short Interest Tracker. Short Interest Increases. Short Interest Decreases. Unusual Call Volume. Unusual Put Volume. This page (NASDAQ:CHRS) was last updated on 2/9/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sign up for MarketBeat All Access to gain access to …...

  • 65 movie trailer

    Pays de cassel psg | 3 days ago · According to the issued ratings of 7 analysts in the last year, the consensus rating for Coherus BioSciences stock is Moderate Buy based on the current 1 hold rating and 6 buy ratings for CHRS. The average twelve-month price prediction for Coherus BioSciences is $11.22 with a high price target of $23.00 and a low price target of $6.00. Learn ... CHRS - Coherus BioSciences, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM) ...

  • Cuban doll

    Tradetapp login | Based on analysts offering 12 month price targets for CHRS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .The stock price of Coherus Biosciences Inc (NASDAQ: CHRS) has dropped by -8.56 compared to previous close of 2.57. Despite this, the company has seen a fall of -23.70% in its stock price over the last five trading days. ... The predicted price for CHRS in the upcoming period, according to Robert W. Baird is $11 based on the research report ...The stock price has risen from 2 to 2.85 since then --- a parity gap still remains as shown in the attached charts ... CHRS - Volume By Price --- Profit Taking ... ...

  • This message has not been downloaded from the server.

    On the silver globe | The average one-year price target for Coherus BioSciences, Inc. is $12.58. The forecasts range from a low of $7.07 to a high of $24.15. A stock’s price target is the price at which analysts consider it fairly valued with respect to its …If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Stock analysis for Coherus Biosciences Inc (CHRS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ...

  • Engine no 9

    Honduras vs. mexico | CHRS stock returns are also predicted based on historical data. According to our research, CHRS stock is a bad long-term investment. CHRS share price has been in a bear cycle for the past year.The 5 analysts with 12-month price forecasts for Coherus BioSciences stock have an average target of 9.60, with a low estimate of 7.00 and a high estimate of 13. The average target predicts an increase of 288.66% from the current stock price of 2.47. ... The average analyst rating for CHRS stock from 6 stock analysts is "Strong Buy". This means ......